Novartis | 销售和管理费用

Selling And Administration Expenses 更改 日
AstraZeneca USD 3.91B 194M 2023-09
Canopy Growth CAD 60.33M 26.29M 2023-09
Gilead Sciences USD 1.61B 293M 2023-12
Prestige Brands USD 65.47M 630K 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Supernus Pharmaceuticals USD 81.28M 1.42M 2023-12



Novartis 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.